BCPC · Earnings event · Q2 2026 · archived
Balchem (BCPC) Q2 2026 earnings — TrendMatrix coverage
Reported · EPS $1.49 vs estimate $1.43 (+4.6%) — classified BEAT.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
EPS beat/miss and revenue
| Metric | Estimate | Actual | Surprise |
|---|---|---|---|
| EPS (diluted) | $1.43 | $1.49 | +4.6% |
| Revenue (2026-06-30) | — | $284.0M | — |
Revenue source: xbrl.
Verdict reaction
How the verdict moved around this report
Before this report, TrendMatrix rated BCPC Hold at 5.9/10. After the Q2 2026 report, the verdict moved to Buy (Wait) at 5.9/10.
Basic Materials context
BCPC at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Specialty Chemicals
- Market cap
- $5.69B
- P/E (fwd)
- 28.5
- P/E (ttm)
- 35.1
- 52-week range
- $139.17–$183.90
- Off 52-week high
- 2.9%
- RSI (14)
- 72
- Volume vs avg
- 0.47×
- Engine score
- 5.8/10
Live context at TrendMatrix’s latest engine read — updates after the report date; not frozen to it.